FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4303946572> ?p ?o ?g. }

• W4303946572 endingPage "85" @default.
• W4303946572 startingPage "85" @default.
• W4303946572 abstract "Anemia is a common feature of both benign and malignant hematologic diseases. Beta-thalassemia (β-thalassemia) syndromes are a group of hereditary disorders characterized by ineffective erythropoiesis, due to a genetic deficiency in the synthesis of the beta chains of hemoglobin, often accompanied by severe anemia and the need for red blood cell (RBC) transfusions. Myelodysplastic syndromes (MDS) are characterized by cytopenia(s) and ineffective hematopoiesis, despite a hypercellular bone marrow. Primary myelofibrosis (PMF) is a clonal myeloproliferative neoplasm characterized by reactive fibrosis of the bone marrow, accompanied by extramedullary hematopoiesis. Luspatercept, previously known as ACE-536, is a fusion protein that combines a modified activin receptor IIB (ActRIIB), a member of the transforming growth factor-β (TGF-β) superfamily, with the Fc domain of human immunoglobulin G (IgG1). It has shown efficacy in the treatment of anemia due to beta β-thalassemia, MDS and PMF and recently gained approval by the Federal Drug Agency (FDA) and the European Medicines Agency (EMA) for transfusion-dependent (TD) patients with β-thalassemia and very low to intermediate-risk patients with MDS with ringed sideroblasts who have failed to respond to, or are ineligible for, an erythropoiesis-stimulating agent. In this review, we describe the key pathways involved in normal hematopoiesis and the possible mechanism of action of luspatercept, present its development and data from the most recent clinical trials in β-thalassemia, MDS and PMF, and discuss its potential use in the treatment of these hematological disorders." @default.
• W4303946572 created "2022-10-10" @default.
• W4303946572 creator A5008138694 @default.
• W4303946572 creator A5049817881 @default.
• W4303946572 creator A5065422184 @default.
• W4303946572 creator A5089326861 @default.
• W4303946572 creator A5090479279 @default.
• W4303946572 date "2022-10-09" @default.
• W4303946572 modified "2023-09-25" @default.
• W4303946572 title "Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis" @default.
• W4303946572 cites W1477594483 @default.
• W4303946572 cites W1499045657 @default.
• W4303946572 cites W1521138540 @default.
• W4303946572 cites W1534089060 @default.
• W4303946572 cites W1995249521 @default.
• W4303946572 cites W2004724289 @default.
• W4303946572 cites W2011733246 @default.
• W4303946572 cites W2017468796 @default.
• W4303946572 cites W2026018207 @default.
• W4303946572 cites W2034825504 @default.
• W4303946572 cites W2051259253 @default.
• W4303946572 cites W2070075266 @default.
• W4303946572 cites W2070982730 @default.
• W4303946572 cites W2077754038 @default.
• W4303946572 cites W2118329428 @default.
• W4303946572 cites W2121743767 @default.
• W4303946572 cites W2129510594 @default.
• W4303946572 cites W2138058759 @default.
• W4303946572 cites W2151573971 @default.
• W4303946572 cites W2255917770 @default.
• W4303946572 cites W2275559463 @default.
• W4303946572 cites W2334344396 @default.
• W4303946572 cites W2337651628 @default.
• W4303946572 cites W2508075031 @default.
• W4303946572 cites W2508716131 @default.
• W4303946572 cites W2557630917 @default.
• W4303946572 cites W2566195742 @default.
• W4303946572 cites W2591426015 @default.
• W4303946572 cites W2609093337 @default.
• W4303946572 cites W2747489535 @default.
• W4303946572 cites W2752628798 @default.
• W4303946572 cites W2754551124 @default.
• W4303946572 cites W2776878294 @default.
• W4303946572 cites W2778275419 @default.
• W4303946572 cites W2794499016 @default.
• W4303946572 cites W2883135363 @default.
• W4303946572 cites W2886141713 @default.
• W4303946572 cites W2900093343 @default.
• W4303946572 cites W2902617203 @default.
• W4303946572 cites W2907774005 @default.
• W4303946572 cites W2909163548 @default.
• W4303946572 cites W2933299555 @default.
• W4303946572 cites W2945562345 @default.
• W4303946572 cites W2946869467 @default.
• W4303946572 cites W2991379201 @default.
• W4303946572 cites W2998901800 @default.
• W4303946572 cites W3014005795 @default.
• W4303946572 cites W3046505142 @default.
• W4303946572 cites W3096492972 @default.
• W4303946572 cites W3097952449 @default.
• W4303946572 cites W3119071615 @default.
• W4303946572 cites W3120315534 @default.
• W4303946572 cites W3211699349 @default.
• W4303946572 cites W3212184523 @default.
• W4303946572 cites W3213974098 @default.
• W4303946572 cites W4200223396 @default.
• W4303946572 cites W4206302502 @default.
• W4303946572 cites W4220950309 @default.
• W4303946572 cites W4283662444 @default.
• W4303946572 cites W4284887577 @default.
• W4303946572 cites W4288075731 @default.
• W4303946572 cites W4294123020 @default.
• W4303946572 doi "https://doi.org/10.3390/diseases10040085" @default.
• W4303946572 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36278584" @default.
• W4303946572 hasPublicationYear "2022" @default.
• W4303946572 type Work @default.
• W4303946572 citedByCount "1" @default.
• W4303946572 countsByYear W43039465722023 @default.
• W4303946572 crossrefType "journal-article" @default.
• W4303946572 hasAuthorship W4303946572A5008138694 @default.
• W4303946572 hasAuthorship W4303946572A5049817881 @default.
• W4303946572 hasAuthorship W4303946572A5065422184 @default.
• W4303946572 hasAuthorship W4303946572A5089326861 @default.
• W4303946572 hasAuthorship W4303946572A5090479279 @default.
• W4303946572 hasBestOaLocation W43039465721 @default.
• W4303946572 hasConcept C109159458 @default.
• W4303946572 hasConcept C126322002 @default.
• W4303946572 hasConcept C2777799968 @default.
• W4303946572 hasConcept C2778080410 @default.
• W4303946572 hasConcept C2778248108 @default.
• W4303946572 hasConcept C2779703530 @default.
• W4303946572 hasConcept C2780007613 @default.
• W4303946572 hasConcept C2780076729 @default.
• W4303946572 hasConcept C2780240888 @default.
• W4303946572 hasConcept C2780366003 @default.
• W4303946572 hasConcept C2780817109 @default.
• W4303946572 hasConcept C2780844101 @default.
• W4303946572 hasConcept C2781107747 @default.

• next